A Phase 4 interventional study of Placebo ethanol and Ethanol in Insomnia, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. Completed at 1 site in United States. Open to participants aged 21 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-02.
Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (part of Viatris Inc.) · Phase 4, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies testing gabapentin in Sleep Initiation and Maintenance Disorders — none open to participants now, none under way, none of them phase 3. Gabapentin · Sleep Initiation and Maintenance Disorders.
Among the 14 studies testing gabapentin in Sleep Initiation and Maintenance Disorders, this one is the 12th largest by enrollment, is one of 3 that started in 2005, is the only one in phase 4, and was the 3rd registered.
2,729 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 731 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →None of the 14 studies testing gabapentin in Sleep Initiation and Maintenance Disorders is open now. The open studies under Sleep Initiation and Maintenance Disorders, anywhere →
Gabapentin: first FDA approval 1993 (NEURONTIN). What it is approved for, and how studies give it, is on its page →
Of the 390 Sleep Initiation and Maintenance Disorders studies recruiting now, 153 (39%) set no upper age limit and 207 (53%) stop at 75 or younger; 59 take children under 18; 109 take healthy volunteers.
This study: 21 Years to 50 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2005.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 68 across 2,356 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 283 across the 14 interventional studies. Of the 14 that completed or were terminated, 2 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 14 have an industry lead sponsor. The 6 most frequent:
This study is registered under Pfizer's Upjohn has merged with Mylan to form Viatris Inc., one of the names counted as Viatris Inc.. Under that name alone:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the lead sponsor of 434 studies on the registry; none are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 8 (89%) have results posted.
Viatris Inc. has 9 studies filed under Sleep Initiation and Maintenance Disorders — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 14 studies testing gabapentin in Sleep Initiation and Maintenance Disorders, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to assess the pharmacodynamic interaction between gabapentin and ethanol
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Placebo ethanol · Drug: Placebo
Drug: Ethanol · Drug: Gabapentin
Drug: Ethanol · Drug: Placebo
Drug: Gabapentin · Drug: Placebo ethanol
Matched placebo ethanol 0.4% in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint
Ethanol 0.7 g/kg in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint
Matched placebo oral capsule with 8 oz of water 2 hours prior to assessment timepoint
Gabapentin 500 mg oral capsule with 8 oz of water 2 hours prior to assessment timepoint
Ethanol 0.7 g/kg in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint
Matched placebo oral capsule with 8 oz of water 2 hours prior to assessment timepoint
Gabapentin 500 mg oral capsule with 8 oz of water 2 hours prior to assessment timepoint
Matched placebo ethanol 0.4% in a total volume of 300 mL as an orange juice cocktail (consumed within 15 minutes) at 1 hour prior to assessment timepoint
Change from pre-dose in the Psychomotor Vigilance Task (PVT) for completed subjects
Time frame: 2 hours post-dose
Change from pre-dose in DSST for Intent-to-Treat (ITTI subjects
Time frame: 2 and 6 hours post-dose
Change from pre-dose in PVT for ITT subjects
Time frame: 2 and 6 hours post-dose
Change from pre-dose in Buschke Selective Reminding Test (BSRT) for completed subjects
Time frame: 2 and 6 hours post-dose
Change from pre-dose in BSRT for ITT subjects
Time frame: 2 and 6 hours post-dose
Change from pre-dose in Stanford Sleepiness Scale (SSS) for completed subjects
Time frame: 2, 6, and 7.5 hours post-dose
Change from pre-dose in SSS for ITT subjects
Time frame: 2, 6, and 7.5 hours post-dose
Adverse events
Time frame: Throughout study duration
Vital signs
Time frame: Throughout study duration
Change from pre-dose in PVT for completed subjects
Time frame: 6 hours post-dose
Change from pre-dose in Digit Symbol Substitution Test (DSST) for completed subjects
Time frame: 2 and 6 hours post-dose
The record gives a start of Apr 2005 and a completion of May 2005. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Ethanol · Gabapentin
Sleep Initiation and Maintenance Disorders →
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. →